Unnecessary polypharmacy in patients with frequent seizures
- 1 January 1984
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 69 (1) , 15-19
- https://doi.org/10.1111/j.1600-0404.1984.tb07774.x
Abstract
Of 35 patients with a mean seizure frequency of 15 attacks per month, 19 were taking a 2-drug combination, 13 a 3-drug combination and 3 patients a 4-drug combination. Treatment was reduced to monotherapy in 21 patients and to a 2-drug combination in 8 patients. There was an increase in seizure frequency in 6 patients taking a 2-drug combination when an attempt was made to reduce the treatment to monotherapy. Reduction in polypharmacy resulted in an improvement in seizure control in 54% of patients. Carbamazepine replaced polypharmacy as monotherapy in 19 patients, and phenytoin and sodium valproate in 2 other patients. Improvement in seizure control was associated with optimal blood levels in 17 patients taking carbamazepine and in the 2 patients taking sodium valproate and phenytoin. Serum levels in all patients taking a 2-drug combination were within the optimal range.Keywords
This publication has 9 references indexed in Scilit:
- Sulthiame in previously untreated epilepsyIrish Journal of Medical Science, 1982
- Anticonvulsant Drugs and Cognitive FunctionsEpilepsia, 1982
- CHANGING TO SINGLE DRUG THERAPY IN EPILEPSYThe Lancet, 1981
- Phenobarbitone in previously untreated epilepsy.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- The therapeutic range for phenytoin — A reappraisalIrish Journal of Medical Science, 1979
- Reduction in polypharmacy for epilepsy.BMJ, 1979
- Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- One drug for epilepsy.BMJ, 1978
- ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSYThe Lancet, 1976